hrze
Showing 1 - 5 of 5
Rifampicin Susceptible Pulmonary Tuberculosis Trial in Cape Town (RESP301, HRZE)
Not yet recruiting
- Rifampicin Susceptible Pulmonary Tuberculosis
- RESP301
- HRZE
-
Cape Town, Bellville, South AfricaTASK Clinical Research Centre
Sep 11, 2023
Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)
Not yet recruiting
- Tuberculous Meningitis
- High dose rifampicin (25mg/kg)
- +8 more
-
Chennai, Tamil Nadu, IndiaICMR- National Institute for Research in Tuberculosis
Jun 15, 2023
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,
Completed
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +5 more
-
Rio de Janeiro, Brazil
- +25 more
Jun 23, 2022
Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)
Recruiting
- Tuberculosis, Pulmonary
- rifampicin
- +3 more
-
Linköping, SwedenLinköping University Hospital
Aug 19, 2021